Pharmaceutical Supply – Lidocaine Hydrochloride and Dextrose Injection
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves the supply and delivery of one package of Lidocaine Hydrochloride and Dextrose Injection to a Department of Defense medical facility, with strict compliance required to both FDA regulations and military-specific standards. The product must meet all applicable quality, formulation, and packaging requirements for use in military healthcare settings, ensuring safety and efficacy under operational conditions. The solicitation is classified as a subcontract and is open for responses until August 10, 2026, with the posting date recorded as August 3, 2026. The North American Industry Classification System code 325412 identifies the procurement as belonging to the pharmaceutical and biological product manufacturing sector. Delivery is to be made to a military installation identified by the FPO zip code 96632, indicating the destination is likely a U.S. military facility overseas or on a naval vessel. The contracting activity falls under the Medical Supply Chain Pharm FSA, underscoring the procurement's focus on sustaining medical readiness through reliable pharmaceutical logistics.
General Info
Agency
NAICS
Place of Performance
FPO, AP, 96632, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
